{"id":78444,"date":"2022-08-18T00:00:00","date_gmt":"2022-08-18T05:00:00","guid":{"rendered":"https:\/\/www.unmc.edu\/newsroom\/2022\/08\/18\/evusheld-available-for-all-immunocompromised-patients\/"},"modified":"2022-09-02T19:55:04","modified_gmt":"2022-09-03T00:55:04","slug":"evusheld-available-for-all-immunocompromised-patients","status":"publish","type":"post","link":"https:\/\/www.unmc.edu\/newsroom\/2022\/08\/18\/evusheld-available-for-all-immunocompromised-patients\/","title":{"rendered":"Evusheld available for all immunocompromised patients"},"content":{"rendered":"

Providers can now order and administer Evusheld for immunocompromised patients in all risk categories. The medication can be stocked and administered within clinics.<\/p>\n

Evusheld (Tixagevimab\/cilgavimab) is indicated as pre-exposure prophylaxis for the prevention of COVID-19 infection in adults and pediatrics 12 years of age and older weighing at least 40 kg.<\/p>\n

Patients must be moderately to severely immunocompromised, such that they are unlikely to mount an adequate immune response to COVID-19 vaccination, or have a history of severe adverse reaction to a COVID-19 vaccine. Patients cannot be currently infected with COVID-19 or have a known recent exposure to the virus.<\/p>\n

This medication has been available under emergency use authorization since December 2021. In order to ensure the most at-risk patients received the medication first, a multidisciplinary team designed a risk matrix<\/a>. From December 2021 to August 2022, patients in risk categories 1 and 2 were offered this therapy. The therapy is now available for patients in all risk categories.<\/p>\n

The medication is administered as two intramuscular injections, one in each gluteal muscle. Injections have been well tolerated based on experience to date. The patient must be monitored for one hour, in the waiting area, after receiving the medication. The medication itself has been purchased by the federal government and is free to patients; however, a $375 administration fee is billed to their insurer. <\/p>\n

Current clinical evidence indicates that the medication should be administered to eligible patients every six months. Clinical evidence regarding the effectiveness of this agent can be found on the EVUSHELD Health Care Providers EUA Fact Sheet<\/a>.<\/p>\n<\/div><\/div>","protected":false},"excerpt":{"rendered":"

The injections were previously only offered to those in highest risk categories.<\/p>\n","protected":false},"author":75,"featured_media":78445,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_relevanssi_hide_post":"","_relevanssi_hide_content":"","_relevanssi_pin_for_all":"","_relevanssi_pin_keywords":"","_relevanssi_unpin_keywords":"","_relevanssi_related_keywords":"","_relevanssi_related_include_ids":"","_relevanssi_related_exclude_ids":"","_relevanssi_related_no_append":"","_relevanssi_related_not_related":"","_relevanssi_related_posts":"","_relevanssi_noindex_reason":"","footnotes":""},"categories":[1],"tags":[],"class_list":["post-78444","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uncategorized","topic-patient-care","department-unmc-today-todays-headlines","author_override-nebraska-medicine"],"yoast_head":"\nEvusheld available for all immunocompromised patients<\/title>\n<meta name=\"description\" content=\"The injections were previously only offered to those in highest risk categories.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.unmc.edu\/newsroom\/2022\/08\/18\/evusheld-available-for-all-immunocompromised-patients\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Evusheld available for all immunocompromised patients\" \/>\n<meta property=\"og:description\" content=\"The injections were previously only offered to those in highest risk categories.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.unmc.edu\/newsroom\/2022\/08\/18\/evusheld-available-for-all-immunocompromised-patients\/\" \/>\n<meta property=\"og:site_name\" content=\"Newsroom\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/unmcedu\" \/>\n<meta property=\"article:published_time\" content=\"2022-08-18T05:00:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2022-09-03T00:55:04+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.unmc.edu\/newsroom\/wp-content\/uploads\/2022\/08\/Evusheld081822.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"705\" \/>\n\t<meta property=\"og:image:height\" content=\"406\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Jeffrey Robb\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@unmc\" \/>\n<meta name=\"twitter:site\" content=\"@unmc\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Jeffrey Robb\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.unmc.edu\/newsroom\/2022\/08\/18\/evusheld-available-for-all-immunocompromised-patients\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.unmc.edu\/newsroom\/2022\/08\/18\/evusheld-available-for-all-immunocompromised-patients\/\"},\"author\":{\"name\":\"Jeffrey Robb\",\"@id\":\"https:\/\/www.unmc.edu\/newsroom\/#\/schema\/person\/6c55382c243ff55b6c4dee62262b6a5c\"},\"headline\":\"Evusheld available for all immunocompromised patients\",\"datePublished\":\"2022-08-18T05:00:00+00:00\",\"dateModified\":\"2022-09-03T00:55:04+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.unmc.edu\/newsroom\/2022\/08\/18\/evusheld-available-for-all-immunocompromised-patients\/\"},\"wordCount\":263,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/www.unmc.edu\/newsroom\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.unmc.edu\/newsroom\/2022\/08\/18\/evusheld-available-for-all-immunocompromised-patients\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.unmc.edu\/newsroom\/wp-content\/uploads\/2022\/08\/Evusheld081822.jpg\",\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/www.unmc.edu\/newsroom\/2022\/08\/18\/evusheld-available-for-all-immunocompromised-patients\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.unmc.edu\/newsroom\/2022\/08\/18\/evusheld-available-for-all-immunocompromised-patients\/\",\"url\":\"https:\/\/www.unmc.edu\/newsroom\/2022\/08\/18\/evusheld-available-for-all-immunocompromised-patients\/\",\"name\":\"Evusheld available for all immunocompromised patients\",\"isPartOf\":{\"@id\":\"https:\/\/www.unmc.edu\/newsroom\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.unmc.edu\/newsroom\/2022\/08\/18\/evusheld-available-for-all-immunocompromised-patients\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.unmc.edu\/newsroom\/2022\/08\/18\/evusheld-available-for-all-immunocompromised-patients\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.unmc.edu\/newsroom\/wp-content\/uploads\/2022\/08\/Evusheld081822.jpg\",\"datePublished\":\"2022-08-18T05:00:00+00:00\",\"dateModified\":\"2022-09-03T00:55:04+00:00\",\"description\":\"The injections were previously only offered to those in highest risk categories.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.unmc.edu\/newsroom\/2022\/08\/18\/evusheld-available-for-all-immunocompromised-patients\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.unmc.edu\/newsroom\/2022\/08\/18\/evusheld-available-for-all-immunocompromised-patients\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.unmc.edu\/newsroom\/2022\/08\/18\/evusheld-available-for-all-immunocompromised-patients\/#primaryimage\",\"url\":\"https:\/\/www.unmc.edu\/newsroom\/wp-content\/uploads\/2022\/08\/Evusheld081822.jpg\",\"contentUrl\":\"https:\/\/www.unmc.edu\/newsroom\/wp-content\/uploads\/2022\/08\/Evusheld081822.jpg\",\"width\":705,\"height\":406},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.unmc.edu\/newsroom\/2022\/08\/18\/evusheld-available-for-all-immunocompromised-patients\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.unmc.edu\/newsroom\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Evusheld available for all immunocompromised patients\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.unmc.edu\/newsroom\/#website\",\"url\":\"https:\/\/www.unmc.edu\/newsroom\/\",\"name\":\"Newsroom\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.unmc.edu\/newsroom\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.unmc.edu\/newsroom\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.unmc.edu\/newsroom\/#organization\",\"name\":\"University of Nebraska Medical Center\",\"url\":\"https:\/\/www.unmc.edu\/newsroom\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.unmc.edu\/newsroom\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.unmc.edu\/newsroom\/wp-content\/uploads\/2022\/08\/overview-1.png\",\"contentUrl\":\"https:\/\/www.unmc.edu\/newsroom\/wp-content\/uploads\/2022\/08\/overview-1.png\",\"width\":500,\"height\":153,\"caption\":\"University of Nebraska Medical Center\"},\"image\":{\"@id\":\"https:\/\/www.unmc.edu\/newsroom\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/unmcedu\",\"https:\/\/x.com\/unmc\",\"https:\/\/instagram.com\/iamunmc\",\"https:\/\/www.youtube.com\/user\/UNMCEDU\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.unmc.edu\/newsroom\/#\/schema\/person\/6c55382c243ff55b6c4dee62262b6a5c\",\"name\":\"Jeffrey Robb\",\"url\":\"https:\/\/www.unmc.edu\/newsroom\/author\/d09bf41544a3365a46c9077ebb5e35c3\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Evusheld available for all immunocompromised patients","description":"The injections were previously only offered to those in highest risk categories.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.unmc.edu\/newsroom\/2022\/08\/18\/evusheld-available-for-all-immunocompromised-patients\/","og_locale":"en_US","og_type":"article","og_title":"Evusheld available for all immunocompromised patients","og_description":"The injections were previously only offered to those in highest risk categories.","og_url":"https:\/\/www.unmc.edu\/newsroom\/2022\/08\/18\/evusheld-available-for-all-immunocompromised-patients\/","og_site_name":"Newsroom","article_publisher":"https:\/\/www.facebook.com\/unmcedu","article_published_time":"2022-08-18T05:00:00+00:00","article_modified_time":"2022-09-03T00:55:04+00:00","og_image":[{"width":705,"height":406,"url":"https:\/\/www.unmc.edu\/newsroom\/wp-content\/uploads\/2022\/08\/Evusheld081822.jpg","type":"image\/jpeg"}],"author":"Jeffrey Robb","twitter_card":"summary_large_image","twitter_creator":"@unmc","twitter_site":"@unmc","twitter_misc":{"Written by":"Jeffrey Robb","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.unmc.edu\/newsroom\/2022\/08\/18\/evusheld-available-for-all-immunocompromised-patients\/#article","isPartOf":{"@id":"https:\/\/www.unmc.edu\/newsroom\/2022\/08\/18\/evusheld-available-for-all-immunocompromised-patients\/"},"author":{"name":"Jeffrey Robb","@id":"https:\/\/www.unmc.edu\/newsroom\/#\/schema\/person\/6c55382c243ff55b6c4dee62262b6a5c"},"headline":"Evusheld available for all immunocompromised patients","datePublished":"2022-08-18T05:00:00+00:00","dateModified":"2022-09-03T00:55:04+00:00","mainEntityOfPage":{"@id":"https:\/\/www.unmc.edu\/newsroom\/2022\/08\/18\/evusheld-available-for-all-immunocompromised-patients\/"},"wordCount":263,"commentCount":0,"publisher":{"@id":"https:\/\/www.unmc.edu\/newsroom\/#organization"},"image":{"@id":"https:\/\/www.unmc.edu\/newsroom\/2022\/08\/18\/evusheld-available-for-all-immunocompromised-patients\/#primaryimage"},"thumbnailUrl":"https:\/\/www.unmc.edu\/newsroom\/wp-content\/uploads\/2022\/08\/Evusheld081822.jpg","inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.unmc.edu\/newsroom\/2022\/08\/18\/evusheld-available-for-all-immunocompromised-patients\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.unmc.edu\/newsroom\/2022\/08\/18\/evusheld-available-for-all-immunocompromised-patients\/","url":"https:\/\/www.unmc.edu\/newsroom\/2022\/08\/18\/evusheld-available-for-all-immunocompromised-patients\/","name":"Evusheld available for all immunocompromised patients","isPartOf":{"@id":"https:\/\/www.unmc.edu\/newsroom\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.unmc.edu\/newsroom\/2022\/08\/18\/evusheld-available-for-all-immunocompromised-patients\/#primaryimage"},"image":{"@id":"https:\/\/www.unmc.edu\/newsroom\/2022\/08\/18\/evusheld-available-for-all-immunocompromised-patients\/#primaryimage"},"thumbnailUrl":"https:\/\/www.unmc.edu\/newsroom\/wp-content\/uploads\/2022\/08\/Evusheld081822.jpg","datePublished":"2022-08-18T05:00:00+00:00","dateModified":"2022-09-03T00:55:04+00:00","description":"The injections were previously only offered to those in highest risk categories.","breadcrumb":{"@id":"https:\/\/www.unmc.edu\/newsroom\/2022\/08\/18\/evusheld-available-for-all-immunocompromised-patients\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.unmc.edu\/newsroom\/2022\/08\/18\/evusheld-available-for-all-immunocompromised-patients\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.unmc.edu\/newsroom\/2022\/08\/18\/evusheld-available-for-all-immunocompromised-patients\/#primaryimage","url":"https:\/\/www.unmc.edu\/newsroom\/wp-content\/uploads\/2022\/08\/Evusheld081822.jpg","contentUrl":"https:\/\/www.unmc.edu\/newsroom\/wp-content\/uploads\/2022\/08\/Evusheld081822.jpg","width":705,"height":406},{"@type":"BreadcrumbList","@id":"https:\/\/www.unmc.edu\/newsroom\/2022\/08\/18\/evusheld-available-for-all-immunocompromised-patients\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.unmc.edu\/newsroom\/"},{"@type":"ListItem","position":2,"name":"Evusheld available for all immunocompromised patients"}]},{"@type":"WebSite","@id":"https:\/\/www.unmc.edu\/newsroom\/#website","url":"https:\/\/www.unmc.edu\/newsroom\/","name":"Newsroom","description":"","publisher":{"@id":"https:\/\/www.unmc.edu\/newsroom\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.unmc.edu\/newsroom\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.unmc.edu\/newsroom\/#organization","name":"University of Nebraska Medical Center","url":"https:\/\/www.unmc.edu\/newsroom\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.unmc.edu\/newsroom\/#\/schema\/logo\/image\/","url":"https:\/\/www.unmc.edu\/newsroom\/wp-content\/uploads\/2022\/08\/overview-1.png","contentUrl":"https:\/\/www.unmc.edu\/newsroom\/wp-content\/uploads\/2022\/08\/overview-1.png","width":500,"height":153,"caption":"University of Nebraska Medical Center"},"image":{"@id":"https:\/\/www.unmc.edu\/newsroom\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/unmcedu","https:\/\/x.com\/unmc","https:\/\/instagram.com\/iamunmc","https:\/\/www.youtube.com\/user\/UNMCEDU"]},{"@type":"Person","@id":"https:\/\/www.unmc.edu\/newsroom\/#\/schema\/person\/6c55382c243ff55b6c4dee62262b6a5c","name":"Jeffrey Robb","url":"https:\/\/www.unmc.edu\/newsroom\/author\/d09bf41544a3365a46c9077ebb5e35c3\/"}]}},"_links":{"self":[{"href":"https:\/\/www.unmc.edu\/newsroom\/wp-json\/wp\/v2\/posts\/78444","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.unmc.edu\/newsroom\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.unmc.edu\/newsroom\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.unmc.edu\/newsroom\/wp-json\/wp\/v2\/users\/75"}],"replies":[{"embeddable":true,"href":"https:\/\/www.unmc.edu\/newsroom\/wp-json\/wp\/v2\/comments?post=78444"}],"version-history":[{"count":1,"href":"https:\/\/www.unmc.edu\/newsroom\/wp-json\/wp\/v2\/posts\/78444\/revisions"}],"predecessor-version":[{"id":87461,"href":"https:\/\/www.unmc.edu\/newsroom\/wp-json\/wp\/v2\/posts\/78444\/revisions\/87461"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.unmc.edu\/newsroom\/wp-json\/wp\/v2\/media\/78445"}],"wp:attachment":[{"href":"https:\/\/www.unmc.edu\/newsroom\/wp-json\/wp\/v2\/media?parent=78444"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.unmc.edu\/newsroom\/wp-json\/wp\/v2\/categories?post=78444"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.unmc.edu\/newsroom\/wp-json\/wp\/v2\/tags?post=78444"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}